Home » Guilford Pharmaceuticals Reports 2005 First Quarter Results
Guilford Pharmaceuticals Reports 2005 First Quarter Results
Guilford Pharmaceuticals reported financial results for the quarter ended March 31, 2005. For the first quarter, Guilford reported a net loss of $54.5 million, or $1.19 per share, compared to a net loss of $18.1 million, or $0.53 per share, for the corresponding period in 2004. Net loss for the first quarter of 2005 included a one time non-cash charge to operations of $31 million relating to the impairment of the intangible assets for Aggrastat Injection (tirofiban HCl) in accordance with SFAS No. 144, "Accounting for Impairment or Disposal of Long-Lived Assets."
Yahoo News (http://biz.yahoo.com/prnews/050509/phm016.html?.v=9)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May